chartexchange

GIKLY
GRIFOLS SA S/ADR
stockOTCADR

EODNov 20, 2026
5.945USD+7.117%(+0.395)152
Loading…
Loading…
Healthcare
Drug Manufacturers-General
HQ
Barcelona, Barcelona, Spain
24,000
Previous Close
$5.55
Beta
-0.56
52-Week High
$6.74 2026-02-18
52-Week Low
$5.06 2026-06-23
SMA 50
$5.54
SMA 200
$5.07
Avg. Vol 10D
1,917
Avg. Vol 30D
1,156
Avg. Vol 90D
18,566
Relative Vol
0.13
852.26M
Jan 5, 2016 · 2-for-1
GIKLY Profile

for more than 75 years, grifols has been improving the health and well-being of people. our patients are our priority, and our commitment to their health has enabled us to become a global healthcare leader with presence in more than 100 countries. the grifols legacy embodies a spirit of innovation and a forward thinking approach and establish us as an international benchmark in the plasma collection market, the production of plasma derived therapies and transfusion medicine. grifols has three business divisions: bioscience brings together all plasma related activities including research, development, collection, production and sales of life-saving plasma derived therapies. diagnostic provides innovative solutions to support safe and compatible transfusions, monitor therapies, and detect infectious and autoimmune diseases. research novel technologies to further improve treatment outcomes and laboratory efficiency. hospital specializes in non-biological pharmaceutical products. t

GIKLY Performance
PeriodPriceDateChangeBeta
1M5.552026-10-01+7.12%0.000
3M5.782026-08-25+2.85%-2.319
6M5.282026-05-26+12.60%-2.173
1Y6.162025-11-12-3.41%-0.557
2Y5.562024-11-19+6.92%—
5Y9.602021-11-23-38.07%-0.293
GIKLY Stock Summary

GRIFOLS SA S/ADR (OTC:GIKLY) stock price today is $5.95, and today's volume is 152. GIKLY is up 7.117% today. The 30 day average volume is 1,156. GIKLY market cap is $5.07B with 852.26M shares outstanding.